SAN JOSE, Calif. & GÖTTINGEN, Germany--(BUSINESS WIRE)--Chronix Biomedical, Inc., a developer of blood-based molecular diagnostics, today announces that it will present data relating to its cell-free DNA copy number instability (CNI) diagnostic at the American Association for Cancer Research (‘AACR’) Annual Meeting 2016 in New Orleans, Louisiana on 19 April 2016.
